Screener Summaries Updates Institutions Sign In More Updates › Financing › IDXX Financing · Nov 13, 2025
IDEXX Laboratories entered into an amendment to its credit agreement to establish a three-year term loan facility and… IDXX Idexx Laboratories Inc
IDEXX Laboratories entered into an amendment to its credit agreement to establish a three-year term loan facility and extend the maturity of its $1.0 billion revolving credit facility to five years. The company also maintains a $250 million unsecured term loan and retains the flexibility to incur up to $250 million in additional incremental credit commitments.
More from Idexx Laboratories Inc IDEXX raises 2026 EPS outlook to $14.96-$15.16 and revenue guidance to $4.74B-$4.77B Nov 2, 2026 IDEXX Laboratories reported second quarter 2026 revenue of $1,217 million, a 10% increase as reported and 9% organic… Aug 4, 2026 IDEXX Laboratories shareholders approved amendments to declassify the Board of Directors over a three-year period and… May 15, 2026 IDEXX Laboratories, Inc. announced its financial results for the first quarter ended March 31, 2026 May 5, 2026 IDEXX Laboratories announced that Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, will… Mar 26, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
